{"certainAgreement":{"otherDetails":"PI agrees to withhold publication until after first multi-center publication or 18 months following study completion, whichever comes first. Additionally, the sponsor can review the results communications prior to public release and can embargo communications regarding the trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"ctx-471-001@compasstherapeutics.com","organization":"Compass Therapeutics","phone":"+1-617-500-8099","title":"Clinical Study Lead"}}